from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1699/pyrG

LFCtreatmentdescriptionclass of inhibitor

-0.154

Amikacinug/mL Amikacintranslation

-0.735

Cap5-10ug/mL Capreomycintranslation

-2.248

Rox10-50 ug/mL Roxithromycintranslation

0.567

SM2-5 ug/mL Streptomycintranslation

0.533

Tet5-10 ug/mL Tetracyclinetranslation

1.937

Rif0.2-5ug/mL Rifampicintranscription

0.098

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.954

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.161

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.525

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.024

Clofazimine10-13 ug/mL Clofaziminerespiration

0.137

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.901

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.435

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.085

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.328

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.146

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.051

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.559

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.606

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.870

KCN5-20 ug/mL Potassium cyaniderespiration

-0.603

NaN30.2-2 mM Sodium aziderespiration

-1.400

Nigericin50 uM Nigericinrespiration

1.537

TRC10-150 ug/mL Triclosanrespiration

-0.793

TRZ10-25 ug/mL Thioridazinerespiration

-0.225

Valinomycin0.5-10 uM Valinomycinrespiration

0.985

ZnSO42 mM ZnSO4respiration

0.383

menadione6-10 ug/mL Menadionerespiration

-0.536

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.617

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.431

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.393

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.495

NRP_1Non-replicating persistence stage 1dosRassociated

0.059

Amp0.2mg/mL AmpicillincellWall

0.009

Cephalexin20-100 ug/mL CephalexincellWall

-1.070

Cerulenin0.32-5 ug/mL CerulenincellWall

0.778

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.535

EMB10-20 ug/mL EthambutolcellWall

0.279

Eta12-40 ug/mL EthionamidecellWall

0.400

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.365

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.834

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.408

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.299

BZA0.12 mg/mL BenzamidearomaticAmides

0.009

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.396

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.032

H2O24 mM hydrogen peroxideDNAdamaging

-0.775

Levo10 ug/mL LevofloxacinDNAdamaging

-0.209

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.651

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.409

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.276

UVUV-irradiationDNAdamaging

-1.256

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.786

Antimycin12.5-50 ug/mL Antimycin A?

-0.244

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.332

PA_110-50 ug/mL Antitubercular compound PA-1?

0.197

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.949

PA8240.2-2 ug/mL PA-824?

0.605

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.132

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.297

Verapamil50 uM Verapamil?

-0.591

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.396

methoxatin10-20 ug/mL Methoxatin?